ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1,2,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
2,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
4,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
5,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
5,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
7,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
8,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
8,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
9,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
10,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
10,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
10,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
10,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
12,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
12,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
13,1,Headache,Headaches NEC,Headaches,Nerv,N
13,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
13,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
14,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
15,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,4,Headache,Headaches NEC,Headaches,Nerv,N
16,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,Y
17,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
18,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
19,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
20,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
21,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
22,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
23,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
24,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
24,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
25,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
25,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
25,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
25,4,Headache,Headaches NEC,Headaches,Nerv,N
25,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
25,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
26,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
27,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
28,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
29,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
30,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
30,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
30,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
30,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
30,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
31,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
32,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
32,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
33,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
33,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
34,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
34,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
34,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
34,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
34,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
36,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
36,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
37,1,Adrenal disorder,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
38,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
39,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
40,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
41,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
41,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
41,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
42,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
42,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
43,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
46,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
46,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
47,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
47,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
48,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
48,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
48,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
48,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
48,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
49,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
50,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
50,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
50,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
50,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
51,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
52,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
52,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
52,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,6,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
52,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
53,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
55,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
55,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
55,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
56,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
57,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
58,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
59,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
60,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
61,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
62,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
62,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
63,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
63,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
63,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
65,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
66,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
67,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
68,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
69,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
69,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
69,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
69,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
69,5,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,6,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
70,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
70,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
71,1,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
72,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
72,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
72,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
73,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
74,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
74,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
74,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
75,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
75,2,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
76,1,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
76,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
77,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
77,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
78,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
78,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
78,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
78,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
78,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
79,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
80,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
82,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
82,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
82,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
83,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
83,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
86,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
87,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
87,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
87,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
87,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
88,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
88,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
88,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
88,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
88,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
88,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
88,7,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
88,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
89,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
89,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
90,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
91,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
91,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
91,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
91,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
91,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
92,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
93,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
93,2,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
93,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
93,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
93,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
94,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
94,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
95,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
95,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
96,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
96,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
96,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
96,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
96,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
96,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
96,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
96,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
96,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
97,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
98,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
99,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Mutism,Communications disorders,Communication disorders and disturbances,Psych,N
102,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
103,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
104,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
105,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
105,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
105,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
106,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
107,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
107,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
108,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
108,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
108,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
108,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
108,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
108,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,7,Prostatic specific antigen abnormal,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
108,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
108,9,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
109,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
110,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
111,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
111,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
112,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
113,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
113,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
113,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
114,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
114,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
114,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
115,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
115,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
115,3,Headache,Headaches NEC,Headaches,Nerv,N
115,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
116,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
117,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
117,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
118,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
118,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
118,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
119,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
119,2,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
119,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
119,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
119,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
120,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
120,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
120,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
120,4,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
120,5,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
121,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
122,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
123,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
123,3,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
124,1,Genital discomfort,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
124,2,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
125,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
125,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
125,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
126,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
126,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
127,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
127,3,Enteral nutrition,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
127,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
127,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
128,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
128,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
128,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
129,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
129,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
129,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
130,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
131,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
132,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
133,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
135,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
135,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
135,3,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
135,4,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
136,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
137,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
138,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
138,3,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
139,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
140,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
141,1,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
141,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
142,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
143,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
144,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
145,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
145,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
145,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
145,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
145,5,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
146,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
146,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
146,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
146,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
146,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
146,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
146,8,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
146,9,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
147,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
148,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
148,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
149,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
150,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
151,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
151,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
151,3,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
151,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
151,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
152,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
153,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
153,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
153,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
153,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
153,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
153,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
153,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
154,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
155,1,Testicular atrophy,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
155,2,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
156,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
157,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
158,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
158,2,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
159,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
160,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
161,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
161,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
161,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
162,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
162,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
163,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
163,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
163,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
164,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
164,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
164,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
164,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
164,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
164,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
164,7,Headache,Headaches NEC,Headaches,Nerv,N
164,8,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
164,9,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
164,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
164,11,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
164,12,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
164,13,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
165,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
166,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
167,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
167,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
168,1,Oedema genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
169,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
169,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
170,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
172,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
173,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
173,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
174,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
175,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
175,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
175,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
175,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
176,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
176,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
177,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
177,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
177,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
177,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
177,6,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
178,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
178,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
178,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
179,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
179,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
179,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
180,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
180,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
180,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
181,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
181,2,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
181,3,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
181,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
182,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
183,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
183,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
183,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
183,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
183,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
183,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
184,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
185,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
185,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
187,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
188,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
189,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
190,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
191,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,2,Tongue neoplasm malignant stage unspecified,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
192,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
193,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
194,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
194,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
194,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
194,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
194,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
195,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
196,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
197,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
197,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
198,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
198,2,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
198,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
198,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
198,7,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
198,8,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
198,9,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
198,10,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
198,11,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
198,12,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
199,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
199,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
199,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
199,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
200,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
201,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
201,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
201,3,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
202,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
203,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
203,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
204,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
204,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
204,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
205,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
205,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
205,3,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
206,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
206,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
206,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
206,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
207,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
207,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
208,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
208,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
209,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
210,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
211,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
212,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
212,2,Cerebral calcification,Structural brain disorders NEC,Structural brain disorders,Nerv,N
212,3,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
213,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
213,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
213,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
214,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
215,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
216,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
217,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
217,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
217,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
217,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
218,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
218,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
218,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
218,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
219,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
220,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
220,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
221,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
222,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
223,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
225,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
226,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
227,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
228,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
228,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
229,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
229,2,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
229,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
230,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
230,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
230,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
231,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
232,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
232,2,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
233,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
234,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
234,2,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
234,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
234,4,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
234,5,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
235,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
236,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
237,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
238,1,Cardiac pacemaker insertion,Cardiac device therapeutic procedures,Cardiac therapeutic procedures,Surg,N
239,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
239,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
240,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
241,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
242,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
243,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
243,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
243,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
243,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,5,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
244,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
244,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
245,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
246,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
246,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
246,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
247,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
248,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
248,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
249,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
249,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
249,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
250,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
251,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
252,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
252,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
252,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
252,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
253,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
254,1,Ammonia abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
254,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
254,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
255,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
255,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
255,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
256,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
257,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
258,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
259,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
260,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
261,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
261,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
262,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
263,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
264,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
264,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
265,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
265,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
266,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
266,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
266,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
267,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
268,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
269,1,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
270,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
271,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
272,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
272,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
272,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
273,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
274,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
275,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
276,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
277,1,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
277,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
277,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
278,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
279,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
279,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
280,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
280,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
281,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
282,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
283,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
284,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
285,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
286,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
286,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
286,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
286,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
286,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
286,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
286,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
287,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
288,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
289,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
289,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
290,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
290,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
291,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
292,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
293,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
293,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
294,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
294,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
294,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
295,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
296,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
297,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
298,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
299,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
299,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
300,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
300,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
300,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
301,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
302,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
302,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
303,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
304,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
304,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
305,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
306,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
306,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
307,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
308,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
309,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
309,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
309,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
309,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
309,5,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
309,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
309,7,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
309,8,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
309,9,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
310,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
311,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
312,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
312,2,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
312,3,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
312,4,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
313,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
314,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
314,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
315,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
316,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
317,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
317,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
317,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
317,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
318,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
318,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
319,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
320,1,Headache,Headaches NEC,Headaches,Nerv,N
320,2,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
321,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
322,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
322,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
322,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
322,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
323,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
324,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
324,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
324,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
324,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,1,Pathological fracture,Fractures NEC,Fractures,Musc,N
325,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
326,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
327,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
327,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
328,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
329,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
329,2,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
330,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
330,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
330,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
330,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
330,5,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
331,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
331,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
332,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
332,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
332,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
332,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
332,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
333,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
334,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
335,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
336,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
336,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
336,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
337,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
338,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
339,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
340,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
341,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
342,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
343,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
343,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
343,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
343,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
343,5,Sticky skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
344,1,Headache,Headaches NEC,Headaches,Nerv,N
344,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
344,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
344,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
346,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
347,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
348,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
349,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
349,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
349,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
350,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
351,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
352,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
352,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
352,3,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
353,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
354,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
355,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
356,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
357,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
357,2,Oesophageal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
358,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
361,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
362,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
362,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
362,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
362,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
363,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
364,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
364,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
364,3,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
364,4,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
364,5,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
365,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
365,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
366,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
366,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
366,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
367,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
368,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
368,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
369,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
369,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
370,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
371,1,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
371,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
371,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
371,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
371,5,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
371,6,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
371,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
371,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
371,9,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
371,10,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
372,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
373,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
374,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
374,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
375,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
375,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
376,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
377,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
378,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
378,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
379,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
379,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
379,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
380,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
381,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
382,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
382,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
382,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
383,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
383,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
383,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
383,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
384,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
386,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
386,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
387,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
388,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
389,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
389,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
389,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
389,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
390,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
391,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
391,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
392,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
393,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
393,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
394,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
395,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
395,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
395,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
396,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
396,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
396,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
396,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
397,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
398,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
398,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
398,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
399,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
399,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
399,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
400,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
400,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
401,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
401,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
402,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
403,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
404,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
405,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
405,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
405,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
406,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
407,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
407,2,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
407,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
407,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
407,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
408,1,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
409,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
409,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
409,3,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
410,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
411,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
411,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
411,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
411,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
411,5,Malignant spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
411,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
412,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
412,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
413,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
413,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
414,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
414,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
414,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
415,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
416,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
416,2,Oscillopsia,Visual disorders NEC,Vision disorders,Eye,N
416,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
417,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
418,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
419,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
419,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
420,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
420,3,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
421,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
421,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
422,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
422,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
422,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
423,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
423,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
424,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
425,2,Headache,Headaches NEC,Headaches,Nerv,N
426,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
426,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
427,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
427,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
427,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
428,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
429,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
429,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
429,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
430,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
431,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
431,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
432,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
433,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
433,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
434,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
435,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
435,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
436,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
437,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
438,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
438,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
438,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
438,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
438,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
438,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
439,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
439,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
440,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
441,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
442,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
443,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
443,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
443,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
444,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
445,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
446,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
447,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
448,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
448,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
448,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
449,1,Migraine,Migraine headaches,Headaches,Nerv,N
450,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
451,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
451,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
452,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
452,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
452,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
453,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
453,2,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
454,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
454,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
455,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
456,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
456,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
456,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
456,4,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
457,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
458,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
458,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
459,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
459,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
459,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
459,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
459,5,Malignant spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
459,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
459,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
459,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
460,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
461,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
461,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
462,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
462,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
463,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
464,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
464,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
464,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
464,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
465,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
465,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
465,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
465,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
465,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
465,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
465,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
465,8,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
465,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
465,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
465,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
465,12,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
465,13,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
465,14,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
466,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
466,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
466,3,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
467,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
467,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
468,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
469,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
470,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
471,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
472,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
473,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
474,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
475,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
476,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
476,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
477,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
477,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
477,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
477,5,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
477,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
477,7,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
477,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
477,9,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
478,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
478,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
479,1,Postictal paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
479,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
480,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
480,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
481,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
482,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
483,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
483,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
484,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
485,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
485,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
486,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
487,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
488,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
488,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
489,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
490,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
491,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
492,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
493,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
494,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
495,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
496,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
497,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
498,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
499,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
500,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
501,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
502,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
503,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
504,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
505,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
508,2,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
509,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
510,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
511,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
512,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
513,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
514,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
515,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
516,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
517,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
518,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
518,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
518,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
518,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
518,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
519,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
522,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
524,1,Blood creatine,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
525,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
526,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
526,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
527,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
528,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
528,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
528,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
528,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
528,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
529,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
530,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
531,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
531,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
531,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
532,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
534,1,Pathological fracture,Fractures NEC,Fractures,Musc,N
534,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
534,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
535,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
535,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
536,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
537,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
538,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
539,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
540,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
541,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
542,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
542,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
543,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
544,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
545,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
546,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
548,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
550,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
551,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
551,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
552,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
553,1,Blood pressure measurement,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
554,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
555,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
556,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
557,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
558,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
558,2,Pharyngeal cancer,Pharyngeal neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
559,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
560,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
560,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
560,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
560,4,Lower urinary tract symptoms,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
560,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
561,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
562,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
563,1,COVID-19 treatment,Antiinfective therapies,Therapeutic procedures and supportive care NEC,Surg,N
564,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
564,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
564,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
565,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
566,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
567,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
567,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
568,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
569,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
571,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
572,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
573,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
574,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
575,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
576,1,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
577,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
577,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
577,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
577,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
577,6,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
577,7,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
577,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
578,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
578,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
579,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
